meta-analysis: insight into the long-term use of dual antiplatelet therapy
Published 8 years ago • 682 plays • Length 4:24Download video MP4
Download video MP3
Similar videos
-
5:16
dapt and pegasus: just how long should patients be on dual antiplatelet therapy?
-
1:26:30
mastering the use of dual antiplatelet therapy for preventing recurrent stroke
-
9:43
optimal duration of dual antiplatelet therapy - video review
-
30:07
the changing face of dual anti-platelet therapy: implications for the internist
-
0:40
ccd guideline - antiplatelet therapy
-
52:11
master dapt trial: dual antiplatelet therapy after coronary stenting - aict-asiapcr 2021
-
12:42
dual antiplatelet therapy: how long is long enough?
-
6:45
dual anti-platelet therapy: how long after pci, cabg, acs?
-
47:23
genotype directed antiplatelet therapy, is the time right?
-
21:57
acs / antithrombotics - s. wassmann
-
4:13
consider clinical presentation when deciding duration of dual-anti-platelet therapy after stenting
-
20:24
long-term dual antiplatelet therapy after pci
-
36:46
journal club - dual antiplatelet therapy after pci in patients at high bleeding risk (master dapt)
-
1:26:30
mastering the use of dual antiplatelet therapy for preventing recurrent stroke
-
24:58
master dapt: dual antiplatelet therapy after coronary stenting in high bleeding risk patients
-
3:11
risk and benefit of prolonged dual antiplatelet therapy (dapt trial) at aha.14
-
9:42
bcis aci 2020: update on dapt — prof robert f storey
-
20:34
onyx one: aspirin vs. p2y12 after 1-month dual antiplatelet therapy for high bleeding risk patients
-
2:52
shorten antiplatelet therapy after coronary stenting?